Management of overactive bladder.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D004599:Electric Stimulation Therapy; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D010353:Patient Education as Topic; D001743:Urinary Bladder / Q000294:innervation; D001745:Urinary Bladder Diseases / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D014554:Urination / Q000502:physiology; D014555:Urination Disorders / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*
D000317:Adrenergic alpha-Antagonists; D018680:Cholinergic Antagonists; D004967:Estrogens; D018727:Muscarinic Antagonists